Atlas Trials

Open Label Extension for Patients Coming From the Dosing Flexibility Study in Patients With Rheumatoid Arthritis (RA)

Clinical trial NCT00753454 · COMPLETED

Trial details

NCT number
NCT00753454
Sponsor
UCB Pharma
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Rheumatoid Arthritis
Start date
2008-09-01
Primary completion
2011-05-01
Enrollment
168

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.